Keywords: gsk, buys, exclusive, rights, otc, lovastatin, merck
GSK buys exclusive rights to OTC lovastatin from Merck & Co; FDA review pending
Article | 03 December 2007
World number two pharmaceutical group, UK-headquartered GlaxoSmithKline says that it has entered into an agreement for over-the-counter marketing rights on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
